Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Heart Drug

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000048954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells: Implications for Vascular Disease

  2001cited by this paper
• Homocysteine and atherothrombosis

  2001cited by this paper
• Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

  2000cited by this paper
• Methylenetetrahydrofolate reductase gene and coronary artery disease.

  2000cited by this paper
• Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

  1999cited by this paper
• Homocysteine and vascular disease.

  1999cited by this paper
• Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

  1998cited by this paper
• Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis.

  1998cited by this paper
• Homocysteine and vitamins in cardiovascular disease.

  1998cited by this paper
• Eat right and take a multivitamin.

  1998cited by this paper
• Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.

  1998cited by this paper
• Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.

  1998cited by this paper
• Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults.

  1998cited by this paper
• No net renal extraction of homocysteine in fasting humans.

  1998cited by this paper
• Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study

  1998cited by this paper
• Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.

  1998cited by this paper
• Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.

  1998cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

  1997cited by this paper
• Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine

  1997cited by this paper
• Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

  1997cited by this paper
• Homocysteine and vascular dysfunction.

  1997cited by this paper
• High Homocysteine Levels Are Independently Related to Isolated Systolic Hypertension in Older Adults

  1997cited by this paper
• Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.

  1997cited by this paper
• Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

  1997cited by this paper
• Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs.

  1997cited by this paper
• Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

  1997cited by this paper
• Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.

  1997cited by this paper
• The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

  1997cited by this paper
• Let's increase folic acid fortification and include vitamin B-12.

  1997cited by this paper
• Plasma homocysteine levels and mortality in patients with coronary artery disease.

  1997cited by this paper
• Correlation between plasma homocyst(e)ine and aortic atherosclerosis.

  1997cited by this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cited by this paper
• High homocysteine levels are independently related to isolated systolic hypertension in older adults.

  1997cited by this paper
• Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase*

  1997cited by this paper
• Folic acid and neural tube defects

  1996cited by this paper
• Folic acid fortification of the food supply. Potential benefits and risks for the elderly population.

  1996cited by this paper
• Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.

  1996cited by this paper
• Homocysteine and cardiovascular disease

  1996cited by this paper
• Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells.

  1996cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.

  1996cited by this paper
• Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.

  1996cited by this paper
• Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects.

  1996cited by this paper
• Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

  1996cited by this paper
• Prevalence of undiagnosed pernicious anemia in the elderly.

  1996cited by this paper
• Folic Acid Food Supplementation: An Idea Whose Time Has Not Come

  1996cited by this paper
• Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.

  1995cited by this paper
• Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

  1995cited by this paper
• Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

  1995cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Serum total homocysteine and coronary heart disease.

  1995cited by this paper
• Homocysteine species as components of plasma redox thiol status.

  1995cited by this paper
• Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction.

  1995cited by this paper
• Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective.

  1995cited by this paper
• Close relation of endothelial function in the human coronary and peripheral circulations.

  1995cited by this paper
• Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.

  1995cited by this paper
• Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer.

  1995cited by this paper
• Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.

  1994cited by this paper
• Vitamin requirements for the treatment of hyperhomocysteinemia in humans.

  1994cited by this paper
• Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol.

  1994cited by this paper
• Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.

  1994cited by this paper
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

  1994cited by this paper
• Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol.

  1994cited by this paper
• A Prospective Study of Plasma Homocyst(e)ine and Risk of Ischemic Stroke

  1994cited by this paper
• Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects.

  1994cited by this paper
• Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.

  1993cited by this paper
• Homocysteine metabolism and the oxidative modification of proteins and lipids.

  1993cited by this paper
• Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population.

  1993cited by this paper
• Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.

  1993cited by this paper
• Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.

  1993cited by this paper
• Total homocysteine in plasma or serum: methods and clinical applications.

  1993cited by this paper
• Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.

  1993cited by this paper
• Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary disease in women.

  1993cited by this paper
• Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.

  1993cited by this paper
• Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.

  1993cited by this paper
• Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents.

  1993cited by this paper
• Homocysteine export from erythrocytes and its implication for plasma sampling.

  1992cited by this paper
• Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.

  1992cited by this paper
• Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.

  1992cited by this paper
• Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

  1992cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.

  1992cited by this paper
• Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.

  1991cited by this paper
• Prevention of neural tube defects : Results of the Medical Research Council Vitamin Study MRC VITAMIN STUDY RESEARCH GROUP

  1991cited by this paper
• The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.

  1991cited by this paper
• Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.

  1990cited by this paper
• A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.

  1990cited by this paper
• Folate intake and food sources in the US population.

  1989cited by this paper
• Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

  1989cited by this paper
• Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency.

  1989cited by this paper
• Measurement of plasma thiols after derivatization with monobromobimane.

  1988cited by this paper
• Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.

  1988cited by this paper
• Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.

  1988cited by this paper
• Folic acid--an innocuous means to reduce plasma homocysteine.

  1988cited by this paper
• Homocysteinemia due to folate deficiency.

  1987cited by this paper
• Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

  1987cited by this paper

• Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity

  2016cites this paper
• Regulation of Spinal Dynorphin 1-17 Release by Endogenous Pituitary Adenylyl Cyclase-Activating Polypeptide in the Male Rat: Relevance of Excitation via Disinhibition

  2011cites this paper
• Formation of μ-/κ-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia

  2010cites this paper
• Increased Spinal Dynorphin Levels and Phospho-Extracellular Signal-Regulated Kinases 1 and 2 and c-Fos Immunoreactivity after Surgery under Remifentanil Anesthesia in Mice

  2010cites this paper
• Tyrosine Phosphorylation of Kir3 following κ-Opioid Receptor Activation of p38 MAPK Causes Heterologous Desensitization*

  2009cites this paper
• Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: A preliminary study on pain memory

  2008cites this paper
• Kappa opioid receptors in the rostral ventromedial medulla of male and female rats

  2007cites this paper
• Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats

  2006cites this paper
• Neurophysiological Underpinnings of Electronic Analgesic Neuromodulation for Dummies

  2006cites this paper
• Cell Signaling and the Genesis of Neuropathic Pain

  2004cites this paper
• Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

  2002cites this paper